ISOC1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.821000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
9.456600E-01
Normal-vs-Stage2
3.771200E-01
Normal-vs-Stage3
1.261470E-03
Normal-vs-Stage4
7.682600E-01
Stage1-vs-Stage2
1.857610E-01
Stage1-vs-Stage3
7.977100E-03
Stage1-vs-Stage4
7.597800E-01
Stage2-vs-Stage3
3.420100E-02
Stage2-vs-Stage4
1.309960E-01
Stage3-vs-Stage4
8.248400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.655400E-01
Normal-vs-AfricanAmerican
6.880800E-01
Normal-vs-Asian
5.270000E-01
Caucasian-vs-AfricanAmerican
5.222000E-01
Caucasian-vs-Asian
9.232600E-01
AfricanAmerican-vs-Asian
6.516200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.164400E-01
Normal-vs-Female
3.579200E-01
Male-vs-Female
7.507200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.676300E-02
Normal-vs-Age(41-60Yrs)
6.645200E-01
Normal-vs-Age(61-80Yrs)
2.882200E-01
Normal-vs-Age(81-100Yrs)
2.699400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.642200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.806400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
9.240200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
4.172300E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.174200E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.133600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.398400E-01
Normal-vs-Daily Drinker
2.590200E-01
Normal-vs-Weekly Drinker
2.909000E-01
Normal-vs-Occasional Drinker
5.794000E-01
Normal-vs-Social Drinker
4.790000E-01
Non Drinker-vs-Daily Drinker
5.854200E-01
Non Drinker-vs-Weekly Drinker
5.065800E-01
Non Drinker-vs-Occasional Drinker
7.263800E-01
Non Drinker-vs-Social Drinker
7.570400E-01
Daily Drinker-vs-Weekly Drinker
8.236400E-01
Daily Drinker-vs-Occasional Drinker
4.098200E-01
Daily Drinker-vs-Social Drinker
4.122600E-01
Weekly Drinker-vs-Occasional Drinker
3.861600E-01
Weekly Drinker-vs-Social Drinker
3.779600E-01
Occasional Drinker-vs-Social Drinker
9.680600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.475780E-02
Normal-vs-Grade 2
2.640400E-03
Normal-vs-Grade 3
3.199800E-03
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.385000E-01
Grade 1-vs-Grade 3
7.680800E-01
Grade 1-vs-Grade 4
1.475780E-02
Grade 2-vs-Grade 3
2.907000E-01
Grade 2-vs-Grade 4
2.640400E-03
Grade 3-vs-Grade 4
3.199800E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.308000E-01
Normal-vs-NonDiabetic
3.254200E-01
Diabetic-vs-NonDiabetic
7.640800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.089560E-01
Normal-vs-NoPancreatitis
3.622000E-01
Pancreatitis-vs-NoPancreatitis
4.158000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.395200E-01
Normal-vs-N1
3.953400E-01
N0-vs-N1
9.714000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
7.222000E-01
Normal-vs-TP53-NonMutant
6.971200E-01
TP53-Mutant-vs-TP53-NonMutant
9.868400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
